UK to Announce Major Multi-million NIH Grant to Launch New Center to Fight Cancer

UK to Announce Major Multi-million NIH Grant to Launch New Center to Fight Cancer

The University of Kentucky was recently awarded a prestigious Centers of Biomedical Research Excellence (COBRE) grant to study the metabolism of cancer from the National Institutes of General Medical Sciences, part of the National Institutes of Health. The $11.2 million grant will fund UK's Center for Cancer and Metabolism over the next five years.

Expanding Precision Medicine Options, Markey Launches Molecular Tumor Board

Expanding Precision Medicine Options, Markey Launches Molecular Tumor Board

The University of Kentucky Markey Cancer Center recently launched its own Molecular Tumor Board, an approach to cancer care that uses genetic analysis to help oncologists choose cancer therapies tailored to each patient's individual needs. The Molecular Tumor Board is the latest precision medicine initiative to come online at Markey.

Proposed Clinical Trial Could Change the Game for Deadly Type of Breast Cancer

Proposed Clinical Trial Could Change the Game for Deadly Type of Breast Cancer

University of Kentucky Markey Cancer Center Oncologist Dr. Edward Romond spent his career at UK treating and studying breast cancer, even leading major Phase 3 clinical trials on the breast cancer drug trastuzumab in the early 2000s. Commonly known as Herceptin, this drug became a standard of care for patients with HER2-positive breast cancer.

Markey Achievements Featured in Annual “State of the Cancer Center” Address at Markey Research Day

Markey Achievements Featured in Annual “State of the Cancer Center” Address at Markey Research Day

Dr. Mark Evers, director of the University of Kentucky Markey Cancer Center, gave his annual "State of the Cancer Center" address Wednesday at Markey Research Day, highlighting the center's major accomplishments in patient care, recruitment, research and outreach from the past year.